Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
Conditions
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Leukemia, Lymphocytic
- Myeloma
- Lymphoma
Interventions
- DRUG: Busulfan
- DRUG: Fludarabine
Sponsor
H. Lee Moffitt Cancer Center and Research Institute